ATYR FY 2024 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$93M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$235,000-33.4% YoY

Gross Profit

$235,000100.0% margin

Operating Income

-$68M-28899.6% margin

Net Income

-$64M-27243.8% margin

EPS (Diluted)

$-0.86

Cash Flow

Operating Cash Flow

-$69M

Free Cash Flow

-$69M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$97M

Total Liabilities

$27M

Stockholders' Equity

$70M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$235,000	$353,000	-33.4%
Gross Profit	$235,000	$353,000	-33.4%
Operating Income	-$68M	-$55M	-23.7%
Net Income	-$64M	-$50M	-27.1%